Amprion, a leader in advancing the diagnosis of neurodegenerative disorders through seed amplification testing, is unveiling its new line of cerebrospinal fluid (CSF) biomarker panels under the SAAmplify brand. These panels provide physicians and patients with the most comprehensive biomarkers…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of KEYTRUDA, Merck’s anti-PD-1 therapy, in…
The Glycocalyx Research Institute is excited to announce groundbreaking results from a recent study exploring the impact of microvascular health—comprising the vast network of tiny capillaries in the body—on acute side effects from radiation therapy in breast, prostate, and head…
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, has announced that Eisai Inc. (the U.S. subsidiary of Tokyo-based Eisai Co., Ltd.) is among the first to adopt its new AI-driven Medidata Clinical Data Studio. Eisai will…
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, has announced the successful closing of its public offering. The offering comprised 6,665,000 shares of common stock and Class A warrants to purchase up to 13,330,000 additional…
Maverick Medical AI has announced a significant expansion of its presence in the United States through a new partnership with a leading national medical provider specializing in the outpatient radiology sector. Within just three months, Maverick successfully transitioned the provider…
Flosonics Medical, a leader in wearable medical ultrasound, today announced that Sutter Health, an integrated not-for-profit system based in Northern California, will implement FloPatch, the world’s first wireless, wearable Doppler ultrasound. The FDA-cleared device gives ICU clinicians a fast, hands-free…
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing cancer treatments, has announced the pricing of its underwritten public offering. The offering consists of 13,333,334 shares of common stock along with warrants to purchase up to 13,333,334 shares, priced…
AtriCure, Inc. (Nasdaq: ATRC), a leader in innovative surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain, has announced regulatory approval from China’s National Medical Products Administration (NMPA) to market and sell its AtriClip® Left…
Conflixis, a pioneering provider of conflict of interest risk management technology, has unveiled its inaugural 2024 Open Payments Report. This comprehensive analysis sheds light on the intricate financial relationships between healthcare providers and the pharmaceutical and medical device industries. “The…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, and Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have announced a master agreement to collaborate on advancing cancer care, particularly for hematological cancers.…
Delphinus Medical Technologies, a groundbreaking innovator in medical imaging, has announced the deployment of its cutting-edge SoftVue™ Breast Ultrasound Tomography (UST) system at McLeod Regional Medical Center in Florence, S.C. This installation marks a significant advancement in breast imaging technology…